NCT04233736

Brief Summary

The goal of this study is to evaluate the analgesic efficacy of bilateral erector spinae plane (ESP) blocks after lumbar and lumbo-sacral spine surgery by assessing postoperative pain scores and opiate requirements as the primary outcome measures. We are aiming to investigate how ESP blocks, performed under ultrasound guidance at the T12 vertebral level, contribute to postoperative pain control. This will be determined by measuring numerical rating pain scores repeatedly following surgery and opiate consumption until patient discharge from hospital. These primary outcome measures will be compared between a treatment group of participants, who will receive ESP blocks and a control group who will receive a sham block. Our primary hypothesis is that ESP blocks significantly reduce postoperative pain and opiate requirements

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

July 23, 2021

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

January 15, 2020

Last Update Submit

July 16, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain scores

    Pain scores will be measured and documented as part of routine clinical care using the standard NRS (numerical rating scale, ranging from 0= no pain to 10= worst imaginable pain). Pain assessments will be made several times per day starting pre-operatively and continued during hospitalization.

    During hospitalization, typically lasting between 1 and 5 days

  • Perioperative opiate consumption

    Peri-operative opiate consumption will be assessed by measuring opiate administration intra- and post-operatively (during hospitalization) and expressed as oral morphine equivalents (OMEs).

    During hospitalization, typically lasting between 1 and 5 days

Study Arms (2)

Treatment group

ACTIVE COMPARATOR
Procedure: Bilateral lumbar erector spinae plane block

Control group

SHAM COMPARATOR
Procedure: Bilateral lumbar erector spinae plane block

Interventions

Bilateral lumbar erector spinae plane blocks performed under ultrasound guidance

Control groupTreatment group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spine surgery at or below the L1 vertebral level
  • Midline surgical approach

You may not qualify if:

  • Previous lumbar or lumbo-sacral surgery with or without hardware placement
  • Evidence of dura pathology (including CSF leak)
  • Spine tumor
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco

San Francisco, California, 94143, United States

RECRUITING

Study Officials

  • Claas Siegmueller, MD PhD MBA

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Claas Siegmueller, MD PhD MBA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2020

First Posted

January 18, 2020

Study Start

July 1, 2021

Primary Completion

November 1, 2021

Study Completion

January 1, 2022

Last Updated

July 23, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations